We are live on
!
Find out more
B
Braidwell Portfolio holdings
AUM
$3B
1-Year Est. Return
46.72%
This Fund
S&P 500
This Quarter
Est. Return
-5.05%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.37B
AUM Growth
-$155M
(-4.4%)
Cap. Flow
-$1B
Cap. Flow
% of AUM
-29.65%
Top 10 Holdings %
Top 10 Hldgs %
37.46%
Holding
95
New
13
Increased
23
Reduced
14
Closed
19
Top Buys
| 1 |
Transmedics
TMDX
|
+$85.8M |
| 2 |
Keros Therapeutics
KROS
|
+$61.7M |
| 3 |
Legend Biotech
LEGN
|
+$59.5M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$49.3M |
| 5 |
Geron
GERN
|
+$28M |
Top Sells
| 1 |
Penumbra
PEN
|
+$40.4M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
+$39M |
| 3 |
Arvinas
ARVN
|
+$31.6M |
| 4 |
APLS
Apellis Pharmaceuticals
APLS
|
+$30.9M |
| 5 |
DexCom
DXCM
|
+$29.6M |
Sector Composition
| 1 | Healthcare | 66.36% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Intuitive Surgical
ISRG
$138B
| $39.3M | 1.17% |
75,300
-16,000
| -18% | -$8.33M |
|
27
Alphatec Holdings
ATEC
$1.39B
| $39.1M | 1.16% |
4,256,490
+215,425
| +5% | +$1.72M |
|
28
BioNTech
BNTX
$23.3B
| $35.3M | 1.05% |
309,865
+62,115
| +25% | +$7.09M |
|
|
BCAX
29
Bicara Therapeutics
BCAX
$1.85B
| $34.9M | 1.03% |
2,000,659
+343,059
| +21% | +$7.14M |
|
30
Krystal Biotech
KRYS
$10.3B
| $31.4M | 0.93% |
200,500
+31,809
| +19% | +$5.64M |
|
31
Harrow
HROW
$1.6B
| $30.4M | 0.9% |
907,039
+467,401
| +106% | +$20.7M |
|
|
32
Keros Therapeutics
KROS
$218M
| $30M | 0.89% |
1,894,439
+1,187,199
| +168% | +$61.7M |
|
|
ORKA
33
Oruka Therapeutics
ORKA
$5.23B
| $27.1M | 0.8% |
1,147,676
+631,950
| +123% | +$15.4M |
|
34
Dianthus Therapeutics
DNTH
$5.46B
| $26.3M | 0.78% |
1,206,589
+712,902
| +144% | +$18.3M |
|
35
OrthoPediatrics
KIDS
$507M
| $25.7M | 0.76% |
1,107,770
| – | – |
|
36
Immatics
IMTX
$1.29B
| $24.9M | 0.74% |
3,503,965
+1,856,400
| +113% | +$16M |
|
|
37
Geron
GERN
$911M
| $24.8M | 0.74% |
+7,006,315
| New | +$28M |
|
38
Ironwood Pharmaceuticals
IRWD
$658M
| $24.1M | 0.71% |
5,440,277
+1,002,045
| +23% | +$4.07M |
|
39
Bruker
BRKR
$8.93B
| $20.7M | 0.61% |
+353,200
| New | +$20.9M |
|
|
EXAS
40
DELISTED
Exact Sciences
EXAS
| $19.8M | 0.59% |
353,000
+66,822
| +23% | +$4.16M |
|
41
Nuvalent
NUVL
$9.81B
| $18.9M | 0.56% |
+241,235
| New | +$22.5M |
|
42
Vaxcyte
PCVX
$8.19B
| $18.2M | 0.54% |
222,424
-75,144
| -25% | -$7.46M |
|
43
Replimune Group
REPL
$813M
| $17.9M | 0.53% |
1,477,102
-1,593,735
| -52% | -$19.4M |
|
44
Dyne Therapeutics
DYN
$3.97B
| $16M | 0.48% |
+681,182
| New | +$20.1M |
|
45
Jasper Therapeutics
JSPR
$19.4M
| $15.3M | 0.45% |
714,658
+231,358
| +48% | +$4.82M |
|
46
Cullinan Oncology
CGEM
$1.1B
| $14.3M | 0.42% |
1,176,173
| – | – |
|
47
Xencor
XNCR
$1.11B
| $14.1M | 0.42% |
615,531
+149,083
| +32% | +$3.43M |
|
48
Candel Therapeutics
CADL
$706M
| $13.9M | 0.41% |
+1,600,000
| New | +$9.45M |
|
49
Arcus Biosciences
RCUS
$3.52B
| $11.9M | 0.35% |
+802,100
| New | +$13.1M |
|
50
Celcuity
CELC
$4.46B
| $11.6M | 0.34% |
884,306
| – | – |
|
Similar funds
NC
VVP
SP
DIG
ECP
PCM
ROTUOC
SM